Page 106 - 202011
P. 106
nese population in Beijing and whites in the United States: of patients with osteoarthritis knee pain:a 13-week,ran-
the Beijing osteoarthritis study[J]. Arthritis Rheum,2001, domized,placebo-controlled trial[J]. Pain,2009,146(3):
44(9):2065-2071. 253-260.
[ 6 ] SHARMA L,CAHUE S,SONG J,et al. Physical function- [15] CHEN L,GONG M,LIU G,et al. Efficacy and tolerabili-
ing over three years in knee osteoarthritis:role of psycho- ty of duloxetine in patients with knee osteoarthritis:a me-
social,local mechanical,and neuromuscular factors[J]. Ar- ta-analysis of randomized controlled trials[J]. Intern Med
thritis Rheum,2003,48(12):3359-3370. J,2019,49(12):1514-1523.
[ 7 ] MURAKI S,AKUNE T,OKA H,et al. Association of ra- [16] FRAKES EP,RISSER RC,BALL TD,et al. Duloxetine
diographic and symptomatic knee osteoarthritis with added to oral nonsteroidal anti-inflammatory drugs for
health-related quality of life in a population-based cohort treatment of knee pain due to osteoarthritis:results of a
study in Japan:the ROAD study[J]. Osteoarthritis Carti- randomized,double-blind,placebo-controlled trial[J]. Cur-
lage,2010,18(9):1227-1234. ren Med Res Opin,2011,27(12):2361-2372.
[ 8 ] BYMASTER FP,LEE TC,KNADLER MP,et al. The du- [17] OSANI MC,BANNURU RR. Efficacy and safety of du-
al transporter inhibitor duloxetine:a review of its preclini- loxetine in osteoarthritis:a systematic review and me-
cal pharmacology,pharmacokinetic profile,and clinical ta-analysis[J]. Korean J Inter Med,2019,34(5):966-
results in depression[J]. Curr Pharm Design,2005,11 973.
(12):1475-1493. [18] UCHIO Y,ENOMOTO H,ALEV L,et al. A randomized,
[ 9 ] REN K,DUBNER R. Neuron-glia crosstalk gets serious: double-blind,placebo-controlled phase Ⅲ trial of dulox-
role in pain hypersensitivity[J]. Curr Opin Anaesthesiol, etine in Japanese patients with knee pain due to osteoar-
2008,21(5):570-579. thritis[J]. J Pain Res,2018,169(11):809-821.
[10] SOFAT N,EJINDU V,KIELY P. What makes osteoarthri- [19] WANG G,BI L,LI X,et al. Efficacy and safety of dulox-
tis painful? The evidence for local and central pain pro- etine in Chinese patients with chronic pain due to osteoar-
cessing[J]. Rheumatology,2011,50(12):2157-2165. thritis:a randomized,double-blind,placebo-controlled
[11] BANNURU RR,OSANI MC,VAYSBROT EE,et al. study[J]. Osteoarthritis Cartilage,2017,25(6):832-838.
OARSI guidelines for the non-surgical management of [20] ARNETT FC,EDWORTHY SM,BLOCH DA,et al. The
knee,hip,and polyarticular osteoarthritis[J]. Osteoarthri- American rheumatism association 1987 revised criteria
tis Cartilage,2019,27(11):1578-1589. for the classification of rheumatoid arthritis[J]. Arthritis
[12] ABOU-RAYA S,ABOU-RAYA A,HELMII M. Dulox- Rheum,1988,31(3):315-324.
etine for the management of pain in older adults with knee [21] FURLAN AD,PENNICK V,BOMBARDIER C,et al.
osteoarthritis:randomised placebo-controlled trial[J]. Age 2009 updated method guidelines for systematic reviews in
Ageing,2012,41(5):646-652. the Cochrane Back Review Group[J]. Spine,2009,34
[13] CHAPPELL AS,DESAIAH D,LIU-SEIFERT H,et al. A (18):1929-1941.
double-blind,randomized,placebo-controlled study of the [22] ENTESHARI-MOGHADDAM A,AZAMI A,ISAZADE-
efficacy and safety of duloxetine for the treatment of HFAR K,et al. Efficacy of duloxetine and gabapentin in
chronic pain due to osteoarthritis of the knee[J]. Pain pain reduction in patients with knee osteoarthritis[J]. Clin
Pract,2011,11(1):33-41. Rheumatol,2019,38(10):2873-2880.
[14] CHAPPELL AS,OSSANNA MJ,LIU-SEIFERT H,et al. (收稿日期:2019-12-13 修回日期:2020-02-27)
Duloxetine,a centrally acting analgesic,in the treatment (编辑:刘明伟)
《中国药房》杂志——中文核心期刊,欢迎投稿、订阅
·1376 · China Pharmacy 2020 Vol. 31 No. 11 中国药房 2020年第31卷第11期